Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.58 |
| ▸ | DRD3 | P35462 | 1/20 | 0.58 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | TRPM8 | Q7Z2W7 | 4/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.42 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | GFER | P55789 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1780107 | 0.98 | DRD2 (0.56) | DRD2DRD3TAAR1TRPM8HSD11B1 | |
| SCHEMBL9281325 | 0.89 | TAAR1 (0.52) | DRD2DRD3TAAR1TRPM8PTGS1 | |
| SCHEMBL5270807 | 0.83 | TAAR1 (0.48) | DRD2DRD3TAAR1TRPM8RIPK1 | |
| SCHEMBL10937071 | 0.82 | DRD2 (0.49) | DRD2DRD3TAAR1TRPM8HSD11B1 | |
| SCHEMBL9309832 | 0.82 | DRD2 (0.47) | DRD2DRD3TAAR1TRPM8HSD11B1 | |
| SCHEMBL2376616 | 0.79 | TAAR1 (0.54) | DRD2DRD3TAAR1HSD11B1PTGS1 | |
| Hydrochloric Acid SCHEMBL4599895 | 0.78 | KDM4E (0.53) | DRD2DRD3TAAR1HSD11B1PTGS1 | |
| SCHEMBL21034335 | 0.77 | DRD2 (0.55) | DRD2DRD3TAAR1HSD11B1PTGS2 | |
| SCHEMBL7005198 | 0.77 | RIPK1 (0.43) | DRD2DRD3TAAR1TRPM8HSD11B1 | |
| SCHEMBL151464 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110118357-A1 | PROCESS FOR PREPARING O-DESMETHYLVENLAFAXINE | GENERICS LIMITED | 2011-05-19 | — | — | US | claimed |
| EP-2200968-A1 | PROCESS FOR PREPARING O-DESMETHYLVENLAFAXINE | Generics Ýuk¨Limited (GB) | 2010-06-30 | — | — | EP | claimed |
| WO-2009053731-A1 | PROCESS FOR PREPARING O-DESMETHYLVENLAFAXINE | GENERICS [UK] LIMITED (GB) | 2009-04-30 | — | — | WO | claimed |
| EP-0136649-B1 | PROCESS FOR THE PREPARATION OF CATIONIC VINYL ESTER BASED POLYMER LATICES AND THEIR USE AS FORMALDEHYDE-FREE BINDERS. | National Starch and Chemical Corporation (US) | 1989-11-15 | — | — | EP | claimed |
| US-20250115545-A1 | TERPENE-CONTAINING LIPIDOIDS FOR GENE DELIVERY | UNIV OF SAN DIEGO (US) | 2025-04-10 | — | — | US | disclosed |
| US-20250099383-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS | UNIVERSITY OF SAN DIEGO | 2025-03-27 | — | — | US | disclosed |
| EP-4231999-B1 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS | POSEIDA THERAPEUTICS INC (US) | 2025-03-05 | — | — | EP | disclosed |
| US-20240018101-A1 | MULTIVALENT TERPENE-BASED BOLAAMPHIPHILES FOR GENE DELIVERY | UNIVERSITY OF SAN DIEGO | 2024-01-18 | — | — | US | disclosed |
| US-20240000969-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS | UNIVERSITY OF SAN DIEGO | 2024-01-04 | — | — | US | disclosed |
| EP-4232015-A1 | MULTIVALENT TERPENE-BASED BOLAAMPHIPHILES FOR GENE DELIVERY | University of San Diego (US) | 2023-08-30 | — | — | EP | disclosed |
| EP-4231999-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS | Poseida Therapeutics, Inc. (US) | 2023-08-30 | — | — | EP | disclosed |
| WO-2023141279-A2 | TERPENE-CONTAINING LIPIDOIDS FOR GENE DELIVERY | UNIVERSITY OF SAN DIEGO (US) | 2023-07-27 | — | — | WO | disclosed |
| US-6124354-A | TREATMENT OF URINARY INCONTINENCE OR IRRITABLE BOWEL SYNDROME | PHARMACIA & UPJOHN AB (SE) | 2000-09-26 | — | — | US | disclosed |
| US-6057332-A | Substituted 1,4-dihydropyrimidine-5-carboxylate compounds, their preparation and uses | ASTRA AKTIEBOLAG (SE) | 2000-05-02 | — | — | US | disclosed |
| WO-2000008001-A1 | SUBSTITUTED ISOXAZOLE AS ESTROGEN RECEPTOR MODULATORS | CHIRON CORPORATION (US) | 2000-02-17 | — | — | WO | disclosed |
| US-4506007-A | TREATED WITH N,N'-DISUBSTITUTED-S-(DIMETHYLAMINO) ETHYTL)-ISOTHIOUREAS | FUJI PHOTO FILM CO., LTD. (JP) | 1985-03-19 | — | — | US | disclosed |
| US-4089891-A | HALOGENATED ALIPHATIC HYDROCARBON | BIOCHEMIE (OE) | 1978-05-16 | — | — | US | disclosed |
| US-4000188-A | ANIONIC SURFACTANTS | CIBA-GEIGY CORPORATION (US) | 1976-12-28 | — | — | US | disclosed |
| US-3933877-A | Hydrophilic and difficultly volatile biocidal triorganometallic compounds | CIBA-GEIGY CORPORATION (US) | 1976-01-20 | — | — | US | disclosed |
| US-3931262-A | Hydrophilic and difficultly volatile biocidal triorganotin compounds | CIBA-GEIGY CORPORATION (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250115545-A1 | TERPENE-CONTAINING LIPIDOIDS FOR GENE DELIVERY | TTPA, NR1H2, NR1H3 | DRD2 4345/4885DRD3 3844/4885TAAR1 4019/4885 |
| US-20240000969-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS | LIPC, CD4, HAVCR2 | DRD2 4847/4885DRD3 4759/4885TAAR1 3178/4885 |
| US-20240018101-A1 | MULTIVALENT TERPENE-BASED BOLAAMPHIPHILES FOR GENE DELIVERY | BOLA2; BOLA2B, GHITM, GGPS1 | DRD2 3628/4885DRD3 3783/4885TAAR1 1351/4885 |
| US-20110118357-A1 | PROCESS FOR PREPARING O-DESMETHYLVENLAFAXINE | ADH5, ADH1C, ADH1A | DRD2 91/4885DRD3 174/4885TAAR1 852/4885 |
| US-20250099383-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS | POLRMT, RNMT, SNRPE | DRD2 4665/4885DRD3 4428/4885TAAR1 3636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.